Related Experiment Video
Updated: May 3, 2026
10:27
Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
10.3K
Direct targeting of Rab-GTPase-effector interactions.
Jochen Spiegel1, Philipp M Cromm, Aymelt Itzen
1Max-Planck-Institut für Molekulare Physiologie, Abteilung Chemische Biologie, Otto-Hahn-Strasse 11, 44227 Dortmund (Germany); Technische Universität Dortmund, Fakultät für Chemie und Chemische Biologie, Otto-Hahn-Strasse 6, 44227 Dortmund (Germany).
Angewandte Chemie (International Ed. in English)
|February 1, 2014
Summary
Researchers developed novel hydrocarbon-stapled peptides to inhibit protein-protein interactions involving Rab GTPases, crucial for cellular processes. One peptide, StRIP3, selectively targets activated Rab8a, offering a new therapeutic strategy for GTPase-related diseases.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- Small GTPases are critical regulators of cellular processes, acting as molecular switches.
- Dysregulation of GTPases is linked to various human diseases.
- Targeting GTPases is challenging due to their extensive and shallow protein interfaces.
Purpose of the Study:
- To develop novel inhibitors for protein-protein interactions involving Rab GTPases.
- To overcome the challenge of targeting GTPase-mediated signaling pathways.
Main Methods:
- Design of hydrocarbon-stapled peptides based on crystal structures of Rab proteins and their interaction partners.
- Evaluation of peptide affinities and inhibitory effects on Rab GTPase-effector interactions.
- In vitro testing of a specific stapled peptide, StRIP3.
Main Results:
- Modified peptides demonstrated significantly increased binding affinities.
- The stapled peptide StRIP3 selectively binds to activated Rab8a.
- StRIP3 effectively inhibits a Rab8a-effector interaction in vitro.
Conclusions:
- Hydrocarbon-stapled peptides represent a promising strategy for inhibiting GTPase-mediated protein-protein interactions.
- StRIP3 shows potential as a selective inhibitor for Rab8a, a key regulator of vesicular transport.
- This approach could lead to new therapeutic interventions for diseases associated with GTPase dysfunction.
More Related Videos
Related Concept Videos
01:14Rab Proteins
4.0K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.0K
01:25Rab Cascades
2.8K
Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
2.8K
01:24Small GTPases - Ras and Rho
4.4K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.4K
01:22Amplifying Signals via Enzymatic Cascade
15.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
01:34Directing Proteins to the Rough Endoplasmic Reticulum
12.0K
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
12.0K
01:26Receptor Tyrosine Kinases
15.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K